TEM Latest Headlines

XAIX, AGIX: Two Best Artificial Intelligence (AI) ETFs to Buy Now

at www.tipranks.com (Thu, 26-Feb 2:07 PM)

Cathie Wood Is Buying The Tempus AI Dip, Ark Snaps Up Stock Worth $11 Million

at www.benzinga.com (Wed, 25-Feb 9:20 PM)

Tempus AI: Accelerating AI-Driven Precision Medicine Growth with Undervalued Long-Term Potential

at www.tipranks.com (Wed, 25-Feb 8:25 AM)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Iovance Biotherapeutics (IOVA), Erasca (ERAS) and Tempus AI, Inc. Class A (TEM)

at www.tipranks.com (Wed, 25-Feb 8:10 AM)

HP, First Solar, Workday And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

at www.benzinga.com (Wed, 25-Feb 8:02 AM)

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Addus Homecare (ADUS) and Tempus AI, Inc. Class A (TEM)

at www.tipranks.com (Wed, 25-Feb 7:30 AM)

Guggenheim Remains a Buy on Tempus AI, Inc. Class A (TEM)

at www.tipranks.com (Wed, 25-Feb 7:28 AM)

Piper Sandler Sticks to Its Hold Rating for Tempus AI, Inc. Class A (TEM)

at www.tipranks.com (Wed, 25-Feb 7:27 AM)

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), BridgeBio Pharma (BBIO) and Establishment Labs Holdings (ESTA)

at www.tipranks.com (Wed, 25-Feb 6:50 AM)

Tempus AI: Diversified Growth, Emerging Profitability, and Valuation Discount Support Overweight Rating

at www.tipranks.com (Wed, 25-Feb 6:45 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and Tempus AI, Inc. Class A (TEM)

at www.tipranks.com (Wed, 25-Feb 5:30 AM)

Tempus AI outlines $1.59B 2026 revenue target with 25% growth guidance, driven by accelerating diagnostics and data businesses

at seekingalpha.com (Tue, 24-Feb 11:58 PM)

Tempus Unveils HRD-RNA Algorithm, Expanding Access to Precision Cancer Therapies

Market Chameleon (Wed, 18-Feb 8:54 AM)

RNA Data Drives Clarity: Ambry Genetics Hits One Million DNA/RNA Tests, Improving Accuracy and Equity in Genetic Diagnostics

Market Chameleon (Mon, 2-Feb 7:09 AM)

Tempus Collaboration Expands Access to Genomic Testing for Northwestern Medicine Cancer Patients

Market Chameleon (Mon, 12-Jan 11:19 AM)

Tempus Collaboration with Northwestern Medicine Signals Expanded Access to Genomic Testing for Cancer Patients

Market Chameleon (Mon, 12-Jan 7:07 AM)

Precision Medicine Advancements Spotlighted: Tempus Presents Eight Breakthrough Abstracts at 2026 ASCO GI Symposium

Market Chameleon (Thu, 8-Jan 8:43 AM)

Tempus AI Spotlights Precision Medicine at J.P. Morgan Healthcare Conference: What Does the 2026 Presentation Reveal about Its Ambitions?

Market Chameleon (Tue, 6-Jan 8:37 AM)